REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS

非编码 RNA 调节胆固醇稳态

• 批准号: 8049125
• 负责人: DANIEL S ORY
• 金额: $ 43.23万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2014-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8049125
• 关键词: Animal Model; Atherosclerosis; Cell Line; Cells; Chinese Hamster Ovary Cell; Cholesterol; Cholesterol Homeostasis; Complement; Computer Simulation; Coupled; Defect; Disease; Elements; Endoplasmic Reticulum; Equilibrium; Event; Exhibits; Exons; Fatty acid glycerol esters; Feedback; Functional RNA; Gene Expression; Gene Targeting; Generations; Genes; Genetic Screening; Genetic Translation; Genomics; Goals; Hereditary Disease; Human; Human Genetics; Inborn Errors of Metabolism; Inborn Genetic Diseases; Introns; Knock-out; Knockout Mice; Laboratories; Maintenance; Mass Spectrum Analysis; Measures; Mediating; Membrane; Membrane Lipids; Metabolic stress; Metabolism; MicroRNAs; Modeling; Molecular; Molecular Target; Nucleotides; Oligonucleotides; Open Reading Frames; Orphan; Pathway interactions; Phenotype; Physiological; Predisposition; Process; Promoter Regions; Proteomics; RNA; RNA Splicing; Regulation; Regulatory Pathway; Role; Small Nucleolar RNA; Small RNA; Sterols; Time; Translations; Walking; base; cell growth regulation; cell type; cholesterol trafficking; drug development; embryonic stem cell; feeding; human DICER1 protein; in vivo; innovation; lipoprotein cholesterol; mRNA Precursor; meetings; mouse model; mutant; novel; promoter; public health relevance; response; trafficking; uptake

DESCRIPTION (provided by applicant): Cellular cholesterol homeostasis is regulated at multiple cholesterol transfer steps and through a negative feedback loop that responds to elevations of membrane cholesterol in the endoplasmic reticulum (ER). Alterations in these sterol sensing and trafficking pathways in contribute to human inborn errors of metabolism and to acquired disease states. To elucidate mechanisms governing these critical cholesterol homeostatic pathways, we performed a functional genetic screen that led to isolation of cell lines with intracellular cholesterol trafficking defects that were enriched in mutants with disruption of long non-coding RNA (ncRNA) genes. These genes exhibit evolutionarily conserved exon/intron organization and core promoter regions, lack significant open reading-frames or nucleotide homology within exons, and contain short, highly conserved intronic regions that harbor small nucleolar RNA (snoRNA) species. This class of long ncRNAs appears principally to serve as host genes to facilitate expressing and processing of the orphan snoRNAs. We hypothesize that the processed snoRNAs modulate expression of genes involved in cholesterol homeostasis, possibly through control of splicing events or translation, and thus represent a previously unrecognized mode of regulation for cellular cholesterol homeostasis. The Specific Aims of this proposal are (1) To characterize ncRNA genes identified by our genetic screen that are critical for maintenance of cholesterol homeostasis, (2) To determine the role of the snoRNA host genes in regulation of intracellular cholesterol transfer and cellular cholesterol homeostasis, (3) To determine the molecular mechanism(s) through which the orphan snoRNA elements exert control over cholesterol regulatory pathways, and (4) To examine the physiological role of the orphan snoRNAs and gene pathways identified through the genetic screen by extending our cell-based studies to in vivo animal models. The proposed studies are innovative in that they explore a novel small RNA-dependent pathway not previously implicated in regulation of cellular cholesterol homeostasis. These studies are highly significant because elucidation of this RNA regulatory pathway has the potential to provide new molecular targets for manipulation of the cellular handling of cholesterol. This proposal is highly relevant to atherosclerosis, a common disease characterized by dysregulation of cholesterol homeostasis, as well as to rare, often fatal inborn errors of sterol metabolism. PUBLIC HEALTH RELEVANCE: Alterations in pathways that regulate cellular cholesterol balance contribute to human genetic diseases and to acquired disease states, such as atherosclerosis. Preliminary studies in our laboratory have identified a set of genes not previously implicated in these cholesterol regulatory pathways. The goal of this proposal is to study how these genes modulate the distribution and level of cholesterol in cells. The proposed studies may identify new targets for drug development for lowering cholesterol in disease states.

描述（由申请人提供）：细胞胆固醇稳态是通过多个胆固醇转移步骤和内质网（ER）中膜胆固醇升高的负反馈回路进行调节的。这些固醇感知和运输途径的改变有助于人类先天性代谢错误和获得性疾病状态。为了阐明控制这些关键胆固醇稳态途径的机制，我们进行了功能性遗传筛选，分离出细胞内胆固醇运输缺陷的细胞系，这些缺陷在长链非编码RNA （ncRNA）基因破坏的突变体中富集。这些基因表现出进化保守的外显子/内含子组织和核心启动子区域，外显子内缺乏显着的开放阅读框或核苷酸同源性，并且包含短的，高度保守的内含子区域，其中包含小核仁RNA （snoRNA）物种。这类长链ncrna似乎主要作为宿主基因，促进孤儿snorna的表达和加工。我们假设，经过加工的snoRNAs可能通过控制剪接事件或翻译来调节胆固醇稳态相关基因的表达，因此代表了一种以前未被认识的细胞胆固醇稳态调节模式。本提案的具体目的是：(1)表征通过我们的遗传筛选确定的对维持胆固醇稳态至关重要的ncRNA基因，(2)确定snoRNA宿主基因在调节细胞内胆固醇转移和细胞胆固醇稳态中的作用，(3)确定孤儿snoRNA元件控制胆固醇调节途径的分子机制。(4)通过将基于细胞的研究扩展到体内动物模型，研究通过遗传筛选确定的孤儿snorna和基因通路的生理作用。提出的研究是创新的，因为他们探索了一种新的小rna依赖途径，以前没有涉及细胞胆固醇稳态的调节。这些研究是非常重要的，因为这种RNA调控途径的阐明有可能为操纵细胞处理胆固醇提供新的分子靶点。这一建议与动脉粥样硬化高度相关，动脉粥样硬化是一种以胆固醇稳态失调为特征的常见疾病，也是罕见的，通常是致命的先天性胆固醇代谢错误。